A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy
- Resource Type
- Article
- Source
- In
Sleep Medicine July 2023 107:202-211 - Subject
- Language
- ISSN
- 1389-9457